Evidence map›Paper›PMID 38660800›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis.

Aaron J Sheppard, Elizabeth H Theng, Sriram S Paravastu, Natalia M Wojnowski, Faraz Farhadi, Michael A Morris, Iris R Hartley, Rachel I Gafni, Kelly L Roszko, Michael T Collins and 1 more

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Cartilage-SpecificBiomedicines · 2025
    Article
  2. Article
  3. Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Aaron J SheppardNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0009-0002-6958-7834
Elizabeth H ThengNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0001-6530-9920
Sriram S ParavastuNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0002-8471-8970
Natalia M WojnowskiNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0001-5193-8451
Faraz FarhadiDepartment of Radiology and Imaging Sciences, Clinical Center (F.F., B.S.), National Institutes of Health, Bethesda, MD.
Michael A MorrisInstitute of Nuclear Medicine, Bethesda, MD (F.F., M.A.M., B.S.).ORCID 0000-0001-9555-904X
Iris R HartleyNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0003-1029-3284
Rachel I GafniNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0002-7970-3491
Kelly L RoszkoNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0002-0284-5299
Michael T CollinsNational Institutes of Dental and Craniofacial Research (A.J.S., E.H.T., S.S.P., N.M.W., I.R.H., R.I.G., K.L.R., M.T.C.), National Institutes of Health, Bethesda, MD.ORCID 0000-0003-3676-7644
Babak SabouryDepartment of Radiology and Imaging Sciences, Clinical Center (F.F., B.S.), National Institutes of Health, Bethesda, MD.ORCID 0000-0002-8632-6292
National Institutes of Health · USNational Institute of Dental and Craniofacial Research · USAmerican Occupational Therapy Association · USDartmouth College · USLouisiana State University in Shreveport · USNorthwestern University · USTwitter (United States) · US

Funding

Skeletal Disorders and Mineral Homeostasis SectionZIADE000649 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI COLLINS, MICHAEL · 2009 to 2025
$32.8M
Intramural NIH HHS Z99 DE999999
6 · The paper itself

Abstract

backgroundVascular calcification causes significant morbidity and occurs frequently in diseases of calcium/phosphate imbalance. Radiolabeled sodium fluoride positron emission tomography/computed tomography has emerged as a sensitive and specific method for detecting and quantifying active microcalcifications. We developed a novel technique to quantify and map total vasculature microcalcification to a common space, allowing simultaneous assessment of global disease burden and precise tracking of site-specific microcalcifications across time and individuals.

methodsTo develop this technique, 4 patients with hyperphosphatemic familial tumoral calcinosis, a monogenic disorder of FGF23 (fibroblast growth factor-23) deficiency with a high prevalence of vascular calcification, underwent radiolabeled sodium fluoride positron emission tomography/computed tomography imaging. One patient received serial imaging 1 year after treatment with an IL-1 (interleukin-1) antagonist. A radiolabeled sodium fluoride-based microcalcification score, as well as calcification volume, was computed at all perpendicular slices, which were then mapped onto a standardized vascular atlas. Segment-wise mCS

resultsPatients with hyperphosphatemic familial tumoral calcinosis had notable peaks in microcalcification score near the aortic bifurcation and distal femoral arteries, compared with a control subject who had uniform distribution of vascular radiolabeled sodium fluoride uptake. This technique also identified microcalcification in a 17-year-old patient, who had no computed tomography-defined calcification. This technique could not only detect a decrease in microcalcification score throughout the patient treated with an IL-1 antagonist but it also identified anatomic areas that had increased responsiveness while there was no change in computed tomography-defined macrocalcification after treatment.

conclusionsThis technique affords the ability to visualize spatial patterns of the active microcalcification process in the peripheral vasculature. Further, this technique affords the ability to track microcalcifications at precise locations not only across time but also across subjects. This technique is readily adaptable to other diseases of vascular calcification and may represent a significant advance in the field of vascular biology.

Indexed as

Fibroblast Growth Factor-23Fluorine RadioisotopesHyperphosphatemiaPositron Emission Tomography Computed TomographyRadiopharmaceuticalsSodium FluorideVascular CalcificationAdolescentAdultCalcinosisFemaleHumansHyperostosis, Cortical, CongenitalMaleMiddle AgedPredictive Value of TestsFGF23 protein, humanFibroblast Growth Factor-23Fluorine-18Fluorine RadioisotopesRadiopharmaceuticalsSodium Fluoridecalcinosismethodspositron-emission tomographyrare diseasesvascular calcification

Identifiers

PMID38660800
PMCPMC11111330
OpenAlexW4395463491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.